PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Prochlorperazine maleate - Vestibular disorders
PAD Profile : Prochlorperazine maleate - Vestibular disorders
Keywords :
vertigo, Menieres disease, labyrinthine disorders, nausea and vomiting
Brand Names Include :
Stemetil, Buccastem
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Cinnarizine
- Cyclizine hydrochloride
- Hyoscine hydrobromide
- Promethazine hydrochloride
- Promethazine teoclate
Other Indications
- Nausea and vomiting (pregnancy)
- Nausea and vomiting
- Nausea and vomiting (chemotherapy induced)
- Nausea and vomiting (post operative)
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Prochlorperazine has been considered by the PCN and has been assigned a GREEN traffic light status.
NOTE - the branded product, Stemetil, was considered BLACK at the PCN in May 2017.
01 July 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status
Associated BNF Codes
04. Central Nervous System
04.06.00. Drugs used in nausea and vertigo